about
Completeness of prescription information in US commercial claims databasesQuantification of missing prescriptions in commercial claims databases: results of a cohort study.Access to and use of $4 generic programs in MedicareThe Prevalence and Predictors of Low-Cost Generic Program Use in the Pediatric Population.Perception of generic prescription drugs and utilization of generic drug discount programs.The relationship between violence in Northern Mexico and potentially avoidable hospitalizations in the USA-Mexico border region.Empirical Assessment of the Impact of Low-Cost Generic Programs on Adherence-Based Quality Measures.Medicare Part D enrollees' use of out-of-plan discounted generic drugs.Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.
P2860
Q33575568-05D5BC32-699C-4F9B-996C-DE8C90B8EDB6Q33578224-A8F01087-48E2-40D4-BB53-270794FF8196Q36243455-9CEE6D9C-BB44-45DE-BA28-9B9470D9752DQ36360206-86A97DAD-3AB4-4C2E-A5DA-916C877B0CC2Q36466028-71D00611-2860-4911-81C7-CDFB259CC2BBQ41385128-DB659E46-0FC4-420D-B0CB-7A7867ABFFFAQ42289314-7DD06B80-C4B8-4368-949A-847931FC374EQ45988140-C374F796-497C-47F4-92F3-D9A302F88325Q47998668-E1D2BAC8-0FFF-47EE-9264-E2BC7BE130F7
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Potential savings from greater use of $4 generic drugs.
@ast
Potential savings from greater use of $4 generic drugs.
@en
Potential savings from greater use of $4 generic drugs.
@nl
type
label
Potential savings from greater use of $4 generic drugs.
@ast
Potential savings from greater use of $4 generic drugs.
@en
Potential savings from greater use of $4 generic drugs.
@nl
prefLabel
Potential savings from greater use of $4 generic drugs.
@ast
Potential savings from greater use of $4 generic drugs.
@en
Potential savings from greater use of $4 generic drugs.
@nl
P1476
Potential savings from greater use of $4 generic drugs
@en
P2093
Walid F Gellad
P304
P356
10.1001/ARCHINTERNMED.2011.46
P407
P50
P577
2011-03-01T00:00:00Z